Your browser doesn't support javascript.
loading
Survival from breast cancer in women with a BRCA2 mutation by treatment.
Evans, D Gareth; Phillips, Kelly-Anne; Milne, Roger L; Fruscio, Robert; Cybulski, Cezary; Gronwald, Jacek; Lubinski, Jan; Huzarski, Tomasz; Hyder, Zerin; Forde, Claire; Metcalfe, Kelly; Senter, Leigha; Weitzel, Jeffrey; Tung, Nadine; Zakalik, Dana; Ekholm, Maria; Sun, Ping; Narod, Steven A.
  • Evans DG; Genomic Medicine, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK.
  • Phillips KA; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.
  • Milne RL; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Fruscio R; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia.
  • Cybulski C; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia.
  • Gronwald J; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia.
  • Lubinski J; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, VIC, Australia.
  • Huzarski T; Department of Medicine and Surgery, University of Milan-Bicocca, Milan, Italy.
  • Hyder Z; Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland.
  • Forde C; Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland.
  • Metcalfe K; Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland.
  • Senter L; Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland.
  • Weitzel J; University of Zielona Góra, Zielona Góra, Poland.
  • Tung N; Genomic Medicine, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK.
  • Zakalik D; Genomic Medicine, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK.
  • Ekholm M; Women's College Research Institute, Women's College Hospital, Toronto, ON, Canada.
  • Sun P; Division of Human Genetics, the Ohio State University Medical Center, Comprehensive Cancer Center, Columbus, OH, USA.
  • Narod SA; Division of Clinical Cancer Genomics, Department of Population Sciences, City of Hope, Duarte, CA, USA.
Br J Cancer ; 124(9): 1524-1532, 2021 04.
Article en En | MEDLINE | ID: mdl-33597716
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Radioterapia / Neoplasias de la Mama / Ovariectomía / Protocolos de Quimioterapia Combinada Antineoplásica / Mutación de Línea Germinal / Proteína BRCA2 / Mastectomía Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Radioterapia / Neoplasias de la Mama / Ovariectomía / Protocolos de Quimioterapia Combinada Antineoplásica / Mutación de Línea Germinal / Proteína BRCA2 / Mastectomía Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Año: 2021 Tipo del documento: Article